- Home
- TGI vs KRRO Comparison
TGI vs KRRO Comparison
Compare TGI & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TGI
- KRRO
- Stock Information
- Founded
- TGI 1993
- KRRO 2014
- Country
- TGI United States
- KRRO United States
- Employees
- TGI N/A
- KRRO N/A
- Industry
- TGI Aerospace
- KRRO Biotechnology: Pharmaceutical Preparations
- Sector
- TGI Industrials
- KRRO Health Care
- Exchange
- TGI Nasdaq
- KRRO Nasdaq
- Market Cap
- TGI 2.0B
- KRRO 125.4M
- IPO Year
- TGI 1996
- KRRO 2019
- Fundamental
- Price
- TGI $25.87
- KRRO $12.90
- Analyst Decision
- TGI Hold
- KRRO Strong Buy
- Analyst Count
- TGI 8
- KRRO 7
- Target Price
- TGI $20.63
- KRRO $85.67
- AVG Volume (30 Days)
- TGI 1.8M
- KRRO 99.7K
- Earning Date
- TGI 08-06-2025
- KRRO 08-12-2025
- Dividend Yield
- TGI N/A
- KRRO N/A
- EPS Growth
- TGI N/A
- KRRO N/A
- EPS
- TGI 0.52
- KRRO N/A
- Revenue
- TGI $1,261,962,000.00
- KRRO $4,821,000.00
- Revenue This Year
- TGI $9.20
- KRRO $65.08
- Revenue Next Year
- TGI $6.89
- KRRO N/A
- P/E Ratio
- TGI $49.33
- KRRO N/A
- Revenue Growth
- TGI 5.87
- KRRO N/A
- 52 Week Low
- TGI $11.01
- KRRO $10.29
- 52 Week High
- TGI $25.96
- KRRO $98.00
- Technical
- Relative Strength Index (RSI)
- TGI 59.13
- KRRO 51.40
- Support Level
- TGI $25.70
- KRRO $12.27
- Resistance Level
- TGI $25.85
- KRRO $15.15
- Average True Range (ATR)
- TGI 0.08
- KRRO 1.13
- MACD
- TGI 0.00
- KRRO 0.25
- Stochastic Oscillator
- TGI 82.61
- KRRO 57.01
About TGI Triumph Group Inc.
Triumph Group Inc designs and manufactures a broad portfolio of aerostructures, aircraft components, and systems for the aviation industry. It serves a customer base of players in the commercial, business, and military markets. The company operates under two operating segments: Systems and Support, which derives key revenue and designs, develops, and supports proprietary components; and Interiors, which supplies commercial and regional manufacturers with aircraft interior systems.
About KRRO Korro Bio Inc.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.